在线客服 
点击这里给我发消息
 
   
400-0909-005
  021-69955236

产品类别
 TCI
 配制试剂
 离子对试剂
 新品推荐
 色素
 酶和辅酶
 对照品
 核苷酸类
 核苷酸类
 抗生素类
 植物生长激素类
 植物生长激素类
 抗生素,生物碱
 抗生素,生物碱
 培养基类
 培养基类
 维生素类
 维生素类
 蛋白类
 蛋白类
 糖类
 碳水化合物
 氨基酸
 缓冲液
 葡聚糖凝胶
 常用色谱类试剂
 实验室常用耗材
 其他类
 其他类
 奎宁系列
推荐产品
新闻中心
2015.4.22 基因组编辑技术利用病态和疾病通过iPS细胞, 创薬研究,再生医疗研究支援(WAKO)
         
Light and pure pharmaceutical research institute and immune special industry Co., is in between in and at last
Industry with over very difficult, and fax, and selling in Kansai, in business coattails contract or concluded (~ hyperplastic massively, and S; ICDRG: (actually I know.
1 reasons of selling up
Technique of STG in non exclusive, chartered in making the plant cells retain Afghan IPS in research technology of retain), (puppet: Itou Yukio Co., Ltd. special immune Research Institute (the agency: Tokyo, the Beijing District, on behalf of the ban servants president the following special immune research institute "), rice with a DoCoMo, and,, Department cellular te fierce, and Ma sytec: fierce, center,,, on continued and compilation of division logoff and mount franchise, and Kiyoshi: (EN), Dhaka design -------- (IMF) field, Co., Ltd.: ANP (Beijing City), on continued iPS cells [in Japanese set, and Kiyoshi (EN). Genetics modification [in Japanese Kansai on continued or for terms terms in experimentation, Kara and center, or actually hyperplastic.
And optical pure pharmaceutical industry Co., Ltd. (the agency: Osaka City Central District, on behalf of the banned existing President: Ohatakey Nobumi, following "and optical pure pharmaceutical industry") is the special immunity of the, retain, in language and in a flying? ", and the compilation of", "no and iPS cell technology is living with environmental and pharmaceutical companies in a pharmaceutical industry Kara, and, national (NVQ), Dhaka design --------, advanced research on necessary here [in Japanese,,, or to provide technique and research support taken Ji -, or expansion (actually I. This agreement is in the back of the long-term development of society or vision in terms into the strategic agreement in case of Na ~ masu this thou.
2 of the content of business cooperation
Special immunity of the Japanese 20 years above [in Japanese left Legend Group and molecular genetics change change animal in Kansai, in Economics Research Institute, laboratory performance in, ", and the compilation of", "no and iPS cells and (U 2 advanced technology or integration on continued language and logoff Kiyoshi much, for a reform of a pharmaceutical research and support aid taken Ji -, or expansion (~ I. The terms CSAC: technology base disc logoff Kiyoshi room, Ma STG note on, Kara, and nado [in Japanese Tsukuba animal [in Japanese Na RA, the, no do not iPS cells in control (the mono tobira,
Objective left genetics sub or, and Noyes Vespa Hikaru and destruction ("no, Vinh phuc, note on into) on continued language and, Ma, Dhaka, genetics and variation left gene in genetics and stroma in import (" of the supplementary material of fries in Ohio, ") on continued language and is left, this Ma De in above in short period, GA analysis of efficiency in a complete language and, may and a much ~ I. For Japanese results, morbid; DNS design, Kara, and, disease no into iPS cells, no do not of iPS cell differentiation / undifferentiated state or Ma, Dhaka, left developmental genetics now Kara high degree in laboratory and with in cell; DNS design Hikaru nado, dependence to Ka Na after for a pharmaceutical and research environment in building (the research study machine Kansai, pharmaceutical enterprises in on continued taken Ji -, or laboratory now); Ma,.
For Japanese tameni puppet, customer de Aru research Kansai, pharmaceutical enterprises in Japan with a intelligence provide logoff by using selling industry with over very difficult, and fax, and de Thou soul ~ I must. And optical pure pharmaceutical industry] have Toyota on continued rich a technology and Economics Research Center, customer and letter of Lai department in base on amplitude of Hiroshima (-, and, kuru in usage (the sytec, taken, expansion has begun, in language and in Kiyoshi book, early career of DPDW: logoff tsunagi, in mono tobira [in Japanese and test ERU, business cooperation as to alleviate ~ hyperplastic.
And optical pure pharmaceutical industrial puppet, special immune Research Institute, provides on continued left gene modification of animal, cell line establish sytec, taken,, and Kiyoshi therefor Kansai even sytec, taken, or domestic] customer: to mount the exclusive logoff by note selling and industry with over very difficult, and fax, activities or play ICDRG: (~ I.
Shen (the promotion of STG support into the vision of establishing high precision STG STG "no use of IPS in laboratory in a pass or no for over very difficult diseases of high, my God for fusion of" s cost and the special immunity of puppet, "and compilation of", "no and iPS cell technology has resolved the,, cancer disease, their immune disorders nado, therapeutics, second, [(design, animal and cell line of ancient for pharmaceutical research support, and Kiyoshi (EN). In the future, I and thou u no and cells in hyperplastic and liver cell Ma note on", "no and immune cells Ma note on" nado Na in vivo evaluation method [in Japanese [in terms of the, a pharmaceutical research and taken to the Lao - [expanding in the book ~ I.

Uteam-BIOTECH
   隐私政策   使用须知   销售条款及条件   售后服务   GHS危&防范声明
   上海跃腾生物科技有限公司UTEAM(SH)         沪ICP备16052474号-1